Xylem (NYSE:XYL - Get Free Report) had its price target dropped by Stifel Nicolaus from $150.00 to $140.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a "buy" rating on the industrial products company's stock. Stifel Nicolaus' target price would indicate a potential upside of 26.67% from the company's previous close.
Several other research firms also recently commented on XYL. Citigroup reduced their price objective on Xylem from $152.00 to $134.00 and set a "buy" rating on the stock in a report on Monday. Robert W. Baird raised their price target on Xylem from $139.00 to $148.00 and gave the company an "outperform" rating in a research note on Wednesday, February 5th. Three equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $147.33.
View Our Latest Stock Report on Xylem
Xylem Trading Up 1.2 %
Xylem stock traded up $1.34 during mid-day trading on Wednesday, hitting $110.53. The company's stock had a trading volume of 2,154,926 shares, compared to its average volume of 1,389,048. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. The company has a 50 day moving average of $120.60 and a 200-day moving average of $123.24. Xylem has a one year low of $100.47 and a one year high of $146.08. The stock has a market cap of $26.90 billion, a PE ratio of 30.20, a P/E/G ratio of 2.33 and a beta of 1.08.
Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Tuesday, February 4th. The industrial products company reported $1.18 EPS for the quarter, topping the consensus estimate of $1.12 by $0.06. The company had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm's revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.99 EPS. On average, research analysts anticipate that Xylem will post 4.65 EPS for the current year.
Institutional Investors Weigh In On Xylem
Institutional investors have recently added to or reduced their stakes in the business. Impax Asset Management Group plc boosted its stake in Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after purchasing an additional 3,883,845 shares in the last quarter. Norges Bank purchased a new stake in shares of Xylem during the fourth quarter valued at $302,734,000. Northern Trust Corp increased its position in shares of Xylem by 42.0% in the 4th quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock valued at $379,204,000 after acquiring an additional 966,399 shares during the period. AMF Tjanstepension AB purchased a new position in Xylem in the 4th quarter worth $96,658,000. Finally, Vaughan Nelson Investment Management L.P. acquired a new stake in Xylem during the 1st quarter worth about $89,828,000. Institutional investors and hedge funds own 87.96% of the company's stock.
About Xylem
(
Get Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.